GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » Gross Profit

Avalon Globocare (Avalon Globocare) Gross Profit : $0.24 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare Gross Profit?

Avalon Globocare's gross profit for the three months ended in Dec. 2023 was $0.09 Mil. Avalon Globocare's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $0.24 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Avalon Globocare's gross profit for the three months ended in Dec. 2023 was $0.09 Mil. Avalon Globocare's Revenue for the three months ended in Dec. 2023 was $0.32 Mil. Therefore, Avalon Globocare's Gross Margin % for the quarter that ended in Dec. 2023 was 26.79%.

Avalon Globocare had a gross margin of 26.79% for the quarter that ended in Dec. 2023 => Competition eroding margins

During the past 10 years, the highest Gross Margin % of Avalon Globocare was 88.15%. The lowest was 18.95%. And the median was 23.93%.

Warning Sign:

Avalon Globocare Corp gross margin has been in long-term decline. The average rate of decline per year is -3.4%.


Avalon Globocare Gross Profit Historical Data

The historical data trend for Avalon Globocare's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Gross Profit Chart

Avalon Globocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.39 0.42 0.27 0.24

Avalon Globocare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.05 0.06 0.04 0.09

Competitive Comparison of Avalon Globocare's Gross Profit

For the Real Estate Services subindustry, Avalon Globocare's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Gross Profit Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Gross Profit distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Gross Profit falls into.



Avalon Globocare Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Avalon Globocare's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=1.256 - 1.018
=0.24

Avalon Globocare's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=0.321 - 0.235
=0.09

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Avalon Globocare's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.09 / 0.321
=26.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Avalon Globocare  (NAS:ALBT) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Avalon Globocare had a gross margin of 26.79% for the quarter that ended in Dec. 2023 => Competition eroding margins


Avalon Globocare Gross Profit Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare (Avalon Globocare) Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751

Avalon Globocare (Avalon Globocare) Headlines

From GuruFocus

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

By GuruFocusNews GuruFocusNews 07-04-2022